The development of stable influenza vaccine powder formulations for new needle-free dosage forms by Amorij, Jean-Pierre
  
 University of Groningen
The development of stable influenza vaccine powder formulations for new needle-free dosage
forms
Amorij, Jean-Pierre
IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from
it. Please check the document version below.
Document Version
Publisher's PDF, also known as Version of record
Publication date:
2008
Link to publication in University of Groningen/UMCG research database
Citation for published version (APA):
Amorij, J-P. (2008). The development of stable influenza vaccine powder formulations for new needle-free
dosage forms. s.n.
Copyright
Other than for strictly personal use, it is not permitted to download or to forward/distribute the text or part of it without the consent of the
author(s) and/or copyright holder(s), unless the work is under an open content license (like Creative Commons).
Take-down policy
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately
and investigate your claim.
Downloaded from the University of Groningen/UMCG research database (Pure): http://www.rug.nl/research/portal. For technical reasons the
number of authors shown on this cover page is limited to 10 maximum.
Download date: 12-11-2019
J-P. Amorij1, J. Meulenaar1, W.L.J. Hinrichs1, T. Stegmann2, A. Huckriede3, 
F. Coenen4, H.W. Frijlink1
Chapter III
Rational design of an influenza subunit 
vaccine powder with sugar-glass-technology:
Preventing conformational changes of haemag-
glutinin during freezing and freeze-drying.
Vaccine 25 (2007): 6447-6457.
1 Department of Pharmaceutical Technology and Biopharmacy, University of 
Groningen, Groningen, The Netherlands.
2 Virosome Biologicals, Leiden, The Netherlands.
3 Department of Medical Microbiology, Molecular Virology Section, University Medical 
Center Groningen and University of Groningen, Groningen, The Netherlands.
4 Solvay Pharmaceuticals, Weesp, The Netherlands.
Abstract
The development of a stable influenza subunit vaccine in the dry state was investigated.
The influence of various carbohydrates, buffer types and freezing rates on the integrity
of haemagglutinin after freeze-thawing or freeze-drying was investigated with a range of
analytical and immunological methods. The use of fast freezing, Hepes buffer and carbo-
hydrates (trehalose, inulin or dextran) as cryo- and lyoprotectants resulted in a sig-
nificant reduction or even absence of conformational changes of haemagglutinin (HA) as
revealed by the used methods. The subunit vaccine in the powder was shown to remain
immunogenic in an in vivo-study in mice, using reconstituted powder. Moreover the HA
potency of the influenza subunit vaccine powder was stable for at least 26 weeks at room
temperature.  
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Introduction
Every year millions of people are infected with influenza resulting in a high morbi-
dity and mortality rate for the elderly and high-risk populations [1]. To control the 
disease, vaccination with influenza vaccines is used. 
The currently used vaccines contain two surface antigens, haemagglutinin (HA) and
neuraminidase (NA). Haemagglutinin, the major surface glycoprotein of the influenza
virus, is a trimer (225 kD) of three identical monomers (75 kD). Each monomer consists
of the polypeptides HA1 (50 kD) and HA2 (25 kD). These polypeptides are linked by two
intramonomer disulfide bridges. The three monomers are assembled into a central α-
helical coiled-coil that forms the stem-like domain, and three globular heads containing
sialic acid-binding sites. Each globular domain consists exclusively of HA1 folded in
highly variable loops of eight antiparallel β-strands. The globular heads contain both the
receptor binding sites and the antigenic epitopes [2, 3].
Haemagglutinin mediates binding of the influenza virus to the cell surface as well as
the subsequent fusion of viral and cellular membranes. The change of the spring-
loaded conformation of HA during fusion follows two stages as reported by Stegmann et
al. [4, 5]. The initial phase is the exposure of the hydrophobic N-termini of the HA2 poly-
peptides and is pH dependent. In the second phase, which is less pH dependent and
occurs after a lag period, major refolding takes place, involving extended coiled coil for-
mation and dissociation of the membrane-distal domains of the protein, exposing clea-
vage sites for trypsin among others. 
Vaccination is a key strategy in the prevention of influenza infection. Vaccines are
generally composed of whole inactivated or attenuated influenza or of (purified) mem-
brane proteins (split vaccine, subunit vaccine). The virus proteins of the  influenza vac-
cine are produced in a solution in which they have a limited physical and chemical sta-
bility. Storage at temperatures below zero, at room temperature as well as at elevated
temperature among others decreases the antigenic potency of haemagglutinin [6, 7]. Carr
et al. found that the conformation change of HA described above can occur in vitro not
only at low pH but also at neutral pH, upon exposure of HA to either heat or the dena-
turant urea [8, 9]. This conformational change results in a reduced or diminished immu-
ne response after vaccination [10].
Currently, influenza vaccines are administered by intramuscular injection. In order
to further stimulate vaccination there is a need for new improved vaccine formulations
that make vaccine delivery easier and safer, decrease dependency on the cold chain
and/or reduce the number of immunization interventions [11]. To overcome the inci-
dence of iatrogenic infections upon immunization of a predominantly healthy populati-
on the development of a needle-free vaccination method, such as jet-injectors, oral,
nasal, aerosol, or patch delivery is required. Furthermore, non-invasive dosage forms
simplify the logistics of immunization, thus improving immunization coverage. 
CHAPTER III
67
One of the keystones in the improvement of vaccine formulations is obtaining 
stable antigen-proteins in the dry state. The most commonly used method for preparing
solid proteinaceous drugs is freeze-drying (lyophilization). However, during freeze-
drying the proteinaceous drug is subjected to freezing and drying stress by which its acti-
vity can be lost. Therefore a protective agent is required to prevent damaging effects of
lyophilization. From literature, it is well known that carbohydrates can protect various
types of drug substances like proteins [12-14] and vaccines [15-17] during freezing, dry-
ing and subsequent storage. If dried properly, the proteinaceous drug is incorporated in
a matrix consisting of carbohydrate in the amorphous glassy state. The stabilizing effect
of these sugar glasses has been explained by the formation of a matrix which strongly
reduces diffusion and molecular mobility (vitrification) and acts as a physical barrier
between particles or molecules (particle/molecule isolation). Both the lack of mobility
[18, 19] and the physical barrier [12, 20] provided by the glass matrix, prevent aggrega-
tion and degradation of the dried material. Moreover, during the lyophilization process,
the water molecules that form H-bonds with the active material are replaced by the
hydroxyl groups of the carbohydrate, by which the 3D-structure/structural integrity of
the active compound is maintained [21]. 
The aim of this research is to design an influenza subunit vaccine powder with full
maintenance of structure and functionality using sugar glass technology. The influence
of freezing rate, buffer composition, and type of carbohydrate on the structure and anti-
genic activity of HA after freezing and freeze-drying respectively is studied. The carbo-
hydrates investigated are a disaccharide (trehalose), an oligosaccharide (inulin) and a
polysaccharide (dextran). 
Maa et al. also incorporated subunit vaccine in sugar glasses [17]. However, they
used a trivalent vaccine (containing A/Panama(H3N2), A/New Caledonia(H1N1) and
B/Yamanashi strains) and predominantly focussed on powder properties and physical
stability, while less attention was paid to structure and functionality of the different
HA's. In the present study, the structural integrity of haemagglutinin (A/Panama(H3N2)
strain) is investigated with a proteolytic assay, fluorescence spectroscopy and circular
dichroism spectroscopy. The antigenic properties of the subunit vaccine powder are
determined by a single radial immunodiffusion assay (SRID) and compared to unproces-
sed subunit vaccine. The antigenic properties of the produced influenza powder after




Influenza sub-unit vaccine of strain A/Panama (H3N2) (monovalent bulk batch number
HPR 40, containing 437 μg/ml HA) was kindly provided by Solvay Pharmaceuticals
(Weesp, The Netherlands). Two different types of inulin, inulin 0.9 kD (SC95; Tg=109°C)
and inulin 1.8 kD (HD0011111; Tg=148°C), were generous gifts from Sensus (Roosendaal,
The Netherlands). Dextran 56 kD (Tg=225°C) from Leuconostoc mesenteroides, was pur-
chased from Fluka Biochemika (Buchs, Switzerland). Trypsin from Bovine Pancreas and
trehalose (Tg=121°C) were from Sigma-Aldrich (Steinheim, Germany). Trypsin-inhibitor
from egg white was purchased from Roche Diagnostics (Darmstadt, Germany). All other
chemicals were of reagent or analytical grade and purchased from commercial suppliers.
Dialysis
The influenza vaccine was dialyzed with Slide-A-Lyzer Dialysis Cassettes (Pierce) with
a molecular weight cut-off of 10 kD to remove thiomersal and to replace buffer and salts.
Four different batches were produced, differing in buffer components (Hepes or 
phosphate buffered) and acid-treatment. Acid-induced change in HA conformation was
provoked by dialyzing the protein against 30 mM citrate buffer, pH 4.75 for 8 hours 
at 37°C. 
The dialyzed samples were then transferred to glass vials and stored in a refrigera-
tor at 4°C until use. The dialysis resulted in batches consisting of:
1. HA in 2.0 mM Hepes buffered saline (HBS), containing 125 mM NaCl, 0.9 mM 
CaCl2*2H2O and 0.5 mM MgCl2*6H2O pH 7.4;
2.    Acid-treated HA in HBS;
3.    HA in phosphate buffered saline (PBS) containing 2.0 mM Na2HPO4*2H2O, 
0.4 mM KH2PO4, 125 mM NaCl, 0.9 mM CaCl2*2H2O and 0.5 mM 
MgCl2*6H2O pH 7.4;
4. Acid-treated HA in PBS.
Freeze-drying and freeze-thawing
Freeze-drying was carried out in a Christ Alpha 1-4 freeze-dryer (Salm en Kipp,
Breukelen, The Netherlands). In a typical experiment, 4 ml glass vials were charged with
0.48 ml aqueous solutions of 360 μg/ml HA and 1.7 % w/v carbohydrate. The solutions
were frozen in the refrigerator for 24 hrs at -20°C or in liquid nitrogen for 5-10 minutes
and subsequently lyophilized or thawed at room temperature. Frozen at -20°C or in
liquid nitrogen will be denoted as slow and rapid freezing, respectively. The freeze-dryer
was set at a shelf temperature of -35°C, a condenser temperature of -55°C and a pressure
of 0.220 mbar. After 24 h the pressure was lowered to 0.060 mbar, and the shelf tem-
perature was gradually increased to 20°C, which was maintained for 24 h. The dry sam-
ples were transferred to a vacuum desiccators at room temperature containing orange
silica gel (EMERGO BV, The Netherlands), where they were kept for at least 2 days. The
CHAPTER III
69
thawed samples were stored in a refrigerator at 4°C until further analysis.   
PH during freezing 
The buffer solutions (HBS and PBS, 1.00 ml, pH 7.4), were mixed with universal indi-
cator (20 μl). The universal indicator contained 0.02% w/v methyl red, 0.02% w/v phe-
nolphthalein, 0.04% w/v bromthymol blue, and 0.04% w/v thymol blue in ethanol [22].
The color of the solutions before and after slow and rapid freezing was noted. Also, buf-
fer solutions containing 1.7 % w/v of carbohydrate and indicator solution were frozen in
order to elucidate the influence of carbohydrate on the pH of the respective buffer so-
lutions during freezing. 
Proteolytic assay with trypsin
In order to evaluate the appearance of an acid-induced conformational change of HA
after freezing and freeze-drying a proteolytic assay was performed. Proteolysis of diluted
HA samples (90 μg/ml) was carried out for 1 hr at pH 7.4 and 37°C with 100 μg/ml tryp-
sin. After 1 hr proteolysis was stopped with 200 μg/ml trypsin-inhibitor. Each sample
(content 3.6 μg HA) was boiled with loading buffer for 5 min. After loading on 10% poly-
acrylamide gels (Fermentas), the (virus) proteins and protein fragments were separated
by SDS-PAGE under non-reducing conditions. Proteins were stained with PAGE blue
staining solution (Fermentas).
Fluorescence Spectroscopy
Fluorescence spectroscopy was performed using a modified version of the method des-
cribed by Luykx et al. [6]. Fluorescence spectra were obtained with a SLM-Aminco AB2
spectrofluorometer at 37°C using cylindrical quartz cuvettes with sample volumes of 
700 μl containing 90 μg/ml HA. An excitation wavelength of 295 nm was used, with 
a band pass of 2.0 nm for the excitation monochromator and 4.0 nm for the emission
monochromator. When excited at 295 nm, the fluorescence emission spectrum is indi-
cative of the localisation within the HA molecule and the degree of solvent exposure of
the 12 tryptophan residues of A/Panama HA [6]. Data were recorded at 1 nm intervals
over the range 300-400 nm. Fluorescence spectra were the average of 5 scans and cor-
rected for background signal caused by buffer, salts or carbohydrate. 
Circular dichroism spectroscopy
CD spectra from 90 μg/ml HA samples were recorded on an Aviv 62A DS CD spectro-
meter at 37°C, using a 0.1 cm path length 200 μl quartz cuvette with continuously N2-
flushing of the sample compartment. Spectra were recorded from 250 to 200 nm (far UV)
with an instrumental time constant of 5 s using a bandwidth of 1 nm and a step reso-
lution of 1 nm. The spectra shown are the average of 12 scans. All spectra are presented
as molar absorbance difference, Δε, based on a mean residue weight of 110 Da and taking




A single radial immunodiffusion (SRID) method was used to test the potency of the 
freeze-dried HA immediately after freeze-drying and after freeze-drying and storage.
Samples were stored up to 26 weeks at 20°C/0%RH (using a silica containing vacuum dis-
siccator in climate controlled room) or at 45°C/11±2%RH in a climate cabinet. The test
is a quantitative immunodiffusion technique and is used as recommended by the
European Pharmacopoeia [23, 24]. 
Immunization
Animal experiments were conducted according to the guidelines provided by the Dutch
Animal Protection Act, and were approved by the Committee for Animal
Experimentation (DEC) of the University of Groningen. For all experiments 6-8 weeks
old female BALB/c mice (Harlan, Zeist, Netherlands) were used. The treated groups 
consisted of 8 mice each and the control group consisted of 3 mice. Mice were injected
intramuscularly in the hind-right leg with a 30 μl sample. Mice received 5 μg unproces-
sed subunit antigen or 5 μg reconstituted inulin-stabilized subunit antigen (as deter-
mined according to the precipitation method of Lowry with trichloro acetic acid [25,
26]). This reconstituted vaccine was previously freeze-dried from an inulin 1.8 kD con-
taining HBS and the powder was stored for 2 weeks at 20°C. The mice of the control
group received only HBS. On day 21 mice were sacrificed. Mice were bled by an orbita
punction under isofluran/oxygen anesthesia. Serum samples were obtained by centrifu-
gation at 11.000 x g. Until the antibody assay, sera were stored at -20°C.
Antibody assays - ELISAs 
Influenza subunit antigen-specific antibody responses were determined by ELISA [27].
ELISA plates (96-well flat bottom, Microlon®600, Greiner, Alphen a/d Rijn,
Netherlands) were coated with 200 ng of influenza subunit antigen per well. Appropriate
dilutions of sera of each individual mouse were applied to the plates, serially diluted 
twofold in PBS/Tween and then incubated for 1 h at 37°C. Subsequently, plates were
washed and incubated with horseradish peroxidase-conjugated goat antibodies directed
against mouse IgG (1:5000). After incubation of the plates with mouse Ig-isotype conju-
gate for 1 h at 37°C, plates were washed twice with PBS/Tween, and once with PBS.
Antibodies were detected using substrate buffer (0.02% 1,2-phenylendiamin-dihydro-
chlorid in 50 mM phosphate buffer pH 5.6, containing 0.006 % H2O2). Plates were 
developed in the dark for 30 min at room temperature after which the reaction was stop-
ped by addition of 50 μl 2 M H2SO4 per well. The absorbance at 490 nm was read with
a Benchmark Microplate reader (BioRad, Hercules, CA). Titers are given as the recipro-
cal of the calculated sample dilution corresponding with an A490 = 0.2 after background
correction. 
Haemagglutination-inhibition assay
For determination of haemagglutination-inhibi-tion (HI) titers in serum, 75 μl of serum
was first inactivated by incubation for 30 min at 56°C [27]. In order to reduce non-spe-
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cific haemagglutination, 225 μl of a 25% kaolin suspension was added. After centri-fuga-
tion for 2 min at 1400 x g, 50 μl of the super-natant was transferred in duplicate to 96-
well round-bottom plates (Greiner, Alphen a/d Rijn, Netherlands) and serially diluted
twofold in PBS. Next 50 μl PBS containing 4 haemagglutination units (HAU) of
A/Panama influenza virus was added to each well. After mixing the contents of each well
gently with a micropipette, the plates were incubated for 40 min at room temperature.
Finally, 50 μl of a 1% guinea pig erythrocyte suspen-sion was added to each well and 
haemagglutination was allowed to proceed for at least 2 h at room temperature. The
highest serum dilution capable of preventing haemagglutination was scored as the HI-
titer. The results are expressed as the geometric mean titer ± standard deviation for each
group.
Statistical analysis 
Comparisons between experimental groups were made using Student's t-test. Probability




As described in the introduction naturally HA mediates both binding and fusion of the
influenza virus, the latter by a pH dependent change in conformation. This conformatio-
nal change can also occur in vitro as a result of low pH (<5.5), resulting in a reduced or
diminished immune response after administration [10]. Because freezing of various buf-
fer solutions can induce a pH shift [28], the effects of freezing on the pH of the buffer
solutions used in this study were investigated. 
In Table I the pH change of two buffer solutions during the freezing processes inves-
tigated are given. During freezing the pH of the PBS in the presence or absence of car-
bohydrates changed from 7.4 to 5.9±0.5 or to 4.4±0.5 after slow or rapid freezing, respec-
tively. Similar pH changes during freezing of PBS were observed by others [28-31]. The
explanation for this effect is that disodium and dipotassium monohydrogen phosphate
crystallize more readily than sodium and potassium dihydrogen phosphate during free-
zing. This results in a strongly decreased pH of the solution, depending on the composi-
tion of the solution [32]. 
The pH change in PBS was larger when rapidly frozen. This larger drop in pH could
be the result of supersaturation as mentioned by Van den Berg et al. [29] Although
Croyle et al. found that in the presence of carbohydrates the pH drops to lower values
when the solution was frozen slowly in stead of rapidly; they found no changes in pH
upon freezing without carbohydrate present [32].
The Hepes-buffered solution changed less then 1 pH unit for both freezing rates
irrespective of the presence or absence of carbohydrates. In the study by Croyle et al. it
was found that when Hepes buffer pH 7.4 was frozen at -20°C with no carbohydrate pre-
sent, the pH dropped about 1.4 units [32]. This larger pH drop may be explained by the
higher concentration of Hepes buffer used (20 mM) than used in the present study (2
mM).  
Table I




Buffer pHa,b (pH units) Freezing by                        pH shiftb (pH units)
PBS 7.4 -20°C ; N2 -2 to -1;      -3
HBS 7.4 -20°C ; N2 -1 to  0;      -1 to 0
a The pH was unaffected after thawing.
b The presence of the carbohydrates used (trehalose, inulin 0.9 kDa, inulin 1.8 kDa or 
dextran 56 kDa) had no effect on pH and pH shifts.
Proteolytic assay
To evaluate whether or not the pH-induced conformational change of HA occurred after
freeze-thawing and freeze-drying, a proteolytic assay with trypsin was performed. In the
native conformation, HA is resistant to digestion by trypsin, but in the acid-induced con-
formation, HA is digested into small fragments. The digestion of HA is readily resolved
by PAGE, providing a convenient assay for the detection of the conformational change
in HA (Fig. 1, A and B). This assay is especially capable in detecting the pH-dependent
conformational change of HA after neutralization [33]. 
Slow freezing of HA in PBS (Fig. 1, C) and freeze-drying of HA in PBS (Fig. 1, E-F)
resulted in a conformational change of HA, although less than observed for the acid
induced change. Slow freezing resulted in increased susceptibility of HA for trypsin clea-
vage compared to rapid freezing. After freeze-drying more HA became susceptible for
trypsin cleavage indicating that during drying a further change in conformation occur-
red. Clearly the presence of carbohydrates resulted in preservation of the spring-loaded 
conformation (Fig. 1, G-J). The use of carbohydrates thus prevented the conformation
change of HA during freeze-drying. 
When PBS was replaced by HBS, no trypsin digestion was observed, neither after 
freeze-thawing nor after freeze-drying in HBS a pH-induced conformational change of
HA occured (data not shown).
Fluorescence spectroscopy
Changes in the tertiary structure of A/Panama HA in PBS or in HBS as a result of  
freezing and freeze-drying were monitored by tryptophan fluorescence spectroscopy
(Fig. 2A and Fig. 2B).
The intrinsic tryptophanyl fluorescence of HA exposed to freezing in PBS revealed
slightly lower fluorescence intensities than was observed for the untreated HA, indepen-
dent of the freezing rate. Slow and fast freezing of HA in HBS instead of PBS showed less
pronounced changes in tryptophanyl fluorescence. Compared to freezing alone, freeze-
drying introduced a more pronounced change in the tryptophan fluorescence spectrum
of HA independent of the buffer used.
Fig. 1 Susceptibility of HA to trypsin digestion. HA was treated as indicated below and analyzed by non-
reducing SDS-PAGE. Shown are the HA monomer bands (75 kD) after different treatments. "Native HA" (A)
and "Acid treated HA" (B) are used as negative and positive control for the trypsin digestion, respectively. The
effect of freeze-thawing and freeze-drying using different freezing rates and PBS is shown in C-F: HA freeze-
thawed using slow freezing (C), freeze-thawed using rapid freezing (D), freeze-dried using slow freezing (E)
and freeze-dried using rapid freezing (F). The effect of the different sugars using a rapid freezing rate and PBS
is shown in G-J: HA freeze-dried with trehalose (G), inulin 0.9 kD (H), inulin 1.8 kD (I) and dextran 56 kD (J). 
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Fig. 2 The effect of freeze-thawing and freeze-drying on the tryptophanyl fluorescence of A/Panama HA
processed in (A) PBS or (B) HBS. Fluorescence spectra of HA untreated (bold solid line), freeze-thawed at -20°C
(solid grey line), freeze-thawed in liquid N2 (solid line), freeze-dried after freezing at -20°C  (dashed line) and
freeze-dried after freezing in liquid N2 (dotted line).
The influence of carbohydrates on the freeze-drying damage of A/Panama HA pro-
cessed with PBS is shown in Figure 3. Freeze-drying in HBS buffer showed the similar
results (data not shown). In contrast to freeze-drying in the absence of carbohydrates,
freeze-drying in the presence of carbohydrates did not result in any significant differen-
ces in fluorescence intensity.
Fig. 3 The influence of sugars on the freeze-drying damage of A/Panama HA processed in PBS using rapid
freezing. Fluorescence spectra were recorded of HA untreated (bold solid line), freeze-dried without sugar
(dotted line), freeze-dried with trehalose (solid grey line),  freeze-dried with inulin 0.9 kD (solid line), freeze-
dried with inulin 1.8 kD (dashed line) and freeze-dried with dextran 56 kD (dashed grey line).
Fig. 4 The effect of freeze-thawing and freeze-drying on the secondary structure of A/Panama HA proces-
sed in (A) PBS or (B) HBS. CD spectra of untreated HA (dotted grey line), frozen-thawed in liquid N2 (solid
line), frozen-thawed at -20°C  (solid grey line), freeze-dried after frozen in liquid N2 (dashed line) and freeze-
dried after frozen at -20°C (dashed grey line).
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Circular Dichroism spectroscopy
The effects of freezing and freeze-drying on the secondary structure of A/Panama HA, as
monitored by far-UV CD spectroscopy, are presented in Figure 4. The far-UV CD spec-
tra of HA in PBS exposed to freezing (both slow or rapid freezing) revealed a somewhat
lower intensity of the negative far-UV CD band than for untreated HA. In contrast to
freezing alone, freeze-drying (both slow or rapid freezing) induced a substantial confor-
mation change. These changes in intensity of the negative far-UV CD band can be ascri-
bed to a conformational change of an α-helix to a more β-sheet structure [6].
When solubilized in HBS, the changes in intensity of the negative far-UV CD band of
HA upon freezing and especially upon freeze-drying were less pronounced than for HA
solubilized in PBS. (see Fig. 4B) Moreover when HA was freeze-dried in HBS after rapid
freezing in the absence of carbohydrates no changes in CD-spectra of the secondary
structure of HA were found.
Furthermore, we investigated the influence of carbohydrates on the integrity of HA
frozen or freeze-dried in PBS or HBS by CD-spectroscopy (Fig. 5A, B). The CD-spectra
indicated that after freeze-drying HA in PBS or in HBS no change in secondary struc-




Besides the structural integrity of HA, as determined by the proteolytic assay, fluores-
cence spectroscopy and circular dichroism spectroscopy, it is essential to investigate the
antigenic properties of the processed subunit vaccine. 
SRID
The antigenic properties of the reconstituted vaccine powder produced by freeze-drying
using rapid freezing were tested in vitro by SRID [23, 24, 34]. In Figure 6 it is shown that
immediately after freeze-drying in PBS without carbohydrate more than 60% of the
antigenic potency was lost while only 25% was lost after freeze-drying in HBS.
Moreover, the vaccine lyophilized from PBS without carbohydrate showed visually
detectable aggregates after reconstitution. In the presence of the carbohydrates the anti-
genic potency was maintained after freeze-drying, irrespective of the type of carbo-
hydrate, indicating that the carbohydrates protected HA during freeze-drying.
Upon storage at 20°C/0%RH, the vaccine freeze-dried without carbohydrate show-
ed a complete loss of potency within 26 weeks (in PBS < 10 weeks). Upon storage only
the vaccines lyophilized without carbohydrate showed visually detectable aggregates
Fig. 5 The effect of sugars on the changes in secundary structure of A/Panama HA induced by freeze-dry-
ing processed in (A) PBS or (B) HBS using rapid freezing. CD spectra were recorded of HA untreated (dotted
grey line), freeze-dried with trehalose (dashed line), freeze-dried with inulin 0.9 kD (dashed grey line), 
freeze-dried with inulin 1.8 kD (solid line), freeze-dried with dextran 56 kD, (solid grey line) and freeze-dried
without sugar (dotted line).
after reconstitution. When the vaccine was incorporated in carbohydrate more than 80%
of the initial HA potency was retained after 26 weeks. Only the HA potency of the vac-
cine incorporated in dextran 56 kD using PBS was more decreased upon storage. 
Upon storage at 45°C/11%RH, all the vaccine powders showed a decrease in HA
potency after 4 weeks, especially when processed without carbohydrate (remaining HA
potency: 0% or 11%, PBS or HBS respectively) or processed with dextran 56 kD (remai-
ning HA potency: 0% or 35%, PBS or HBS respectively). After 4 weeks of storage at
45°C/11%RH, the HA potencies of vaccines freeze-dried with trehalose, inulin 0.9 kD
and inulin 1.8 kD from PBS were 77, 76, and 62%, respectively. The same trend was
shown for dry vaccine produced from HBS-buffered material. However upon prolonged
storage, the HA potency of the vaccine powders containing either of the two inulins 
further declined. Only the vaccine incorporated in trehalose retained around 80% of its
potency after 26 weeks of storage. Overall the vaccine powders produced from PBS
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Fig. 6 The effect of carbohydrate and buffer on the antigen stability of the freeze-dried subunit vaccine.
HA potency was evaluated by SRID during storage for 26 weeks at 20°C 0%RH (upper panels: A and B) or at
45°C 11%RH (lower panels: C and D). Vaccine powder produced from PBS and HBS are presented in the left
(A and C) and right panels (B and D), respectively. Vaccine is freeze-dried using rapid freezing without carbo-
hydrate (open circles), with trehalose (crosses), inulin 0.9 kD (open triangles), inulin 1.8 kD (closed diamonds)
or dextran 56kD (closed squares).
Fig. 7 Subunit antigen-specific IgG serum titers (white bars) and serum HI titers (shaded bars) in mice.
Animals were immunized i.m. with 5 μg subunit antigen from unprocessed or reconstituted lyophilized inulin
1.8 kD-A/Panama subunit vaccine. Antigen-specific IgG responses and serum HI titers in mice receiving 
lyophilized inulin 1.8kD-subunit antigen were equal to animals immunized with unprocessed subunit antigen 
(P > 0.9, Student's t-test). The results are expressed as the geometric mean titer ± standard deviation for each
group.
showed a more pronounced decrease in antigen content compared to vaccine powder
produced from HBS. In none of the vaccine formulations containing carbohydrates 
visual aggregates were observed after lyophilization, storage and subsequent reconstitu-
tion.
Immunological response in mice
The antigenic properties of the subunit vaccine powder were further evaluated by intra-
muscular immunization of mice. To keep the number of mice small we only investigated
the immunogenic properties of reconstituted subunit vaccine powder, freeze-dried in
HBS, using inulin (1.8 kD) as stabilizer and rapid freezing. Untreated subunit vaccine and
HBS were used as a positive and negative control, respectively.
The results of the immunization of mice are presented in Figure 7. It was found that
the antigen-specific IgG responses in mice immunized with reconstituted inulin lyophi-
lized subunit antigen or unprocessed subunit antigen were almost identical (P > 0.9,
Student's t-test). Intramuscular administration of pure HBS induced no significant anti-
gen-specific IgG responses (data not shown).
Furthermore, the virus-binding capacity of the sera was assessed in an HI assay
using influenza A/Panama virus and guinea pig erythrocytes. It was found that the HI-
titers induced by reconstituted lyophilized subunit antigen and by unprocessed subunit
antigen were also not significantly different (P > 0.9, Student's t-test). In addition, no sig-




This study clearly shows that with the proper choice of buffer, lyoprotectant and process
conditions, intact influenza subunit vaccine can be obtained as a powder in which HA
maintained its structure and functionality according to the analytical and immunologi-
cal methods used.
The structural integrity of haemagglutinin
During freeze-drying HA is exposed to freezing and dehydration stresses. To evaluate
whether possible deterioration of the protein is due to freezing or dehydration stresses
during the freezing or drying step of the cycle, the structure of HA after freeze-thawing
or freeze-drying was investigated. The combination of the proteolytic assay, fluorescen-
ce spectroscopy and circular dichroism spectroscopy was used because they are capable
to indicate changes in the spring-loaded conformation, tertiary structure and secondary
structure of HA, respectively.
The effect of freeze-thawing on the structural integrity of HA was found to depend
on the type of buffer and freezing rate. While dissolved in HBS the structure of HA
changed only slightly, the secondary structure and tertiary structure of HA were more
affected upon freezing in PBS. This difference is explained by the fact that freezing of
HBS resulted in a much smaller decrease of the pH than freezing of PBS. As a consequen-
ce, the acid-induced conformation change of HA during freezing occurred only in PBS. 
Surprisingly, a less pronounced acid-induced conformational change of HA in PBS
was found after rapid freezing than after slow freezing, although the pH of the PBS dec-
reased more strongly. Two reasons may explain this result. First, the pH drop after rapid
freezing is misleading due to supersaturation [29]. Secondly, the system is rapidly vitri-
fied during rapid freezing which may prevent the conformational change to occur.
Slow freezing in PBS caused structural changes of HA (exposed trypsin cleavage
sites), despite the moderate pH-shift (not below 5.5). Moreover, these structural changes
were not prevented by the low temperature, which in general slows down the pH-indu-
ced conformation change of HA [4, 5, 35]. This can be ascribed to the increase in solute
concentration of the non-frozen fraction during freezing, resulting in acceleration of
reaction kinetics [36] and changed physical properties such as ionic strength and relati-
ve composition of the solution, which may destabilize the protein [12].
In addition fluorescence and CD-spectroscopy of HA after freeze thawing indicate
that the conformational changes of HA after freezing are not induced by a low pH alone,
but also by freezing related stresses. Upon accidification of HA fluorescence and CD
spectra changes, as reported in [6, 37, 38] and [6, 35], respectively. However, these spec-
tral changes were found to be reversible after subsequent neutralization [35, 38]. We also
found no decrease in intrinsic tryptophanyl fluorescence after acidification of HA from
A/Panama at 37°C (pH 4.75) and subsequent neutralization (data not shown).
Consequently the reversibility of a pH related conformational change of HA would indi-
cate that structural changes of HA revealed by fluorescence and CD-spectroscopy are not
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the result of a pH-shift (alone). This is further supported by the study of Luykx et al. [6]
who found similar decreased intrinsic tryptophanyl fluorescence upon freeze-thawing
while no pH change appeared upon freezing. In contrast, the lack of changes in the
secondary and tertiary structure of HA freeze-thawed in HBS may indicate that Hepes
acts as a cryoprotectant.
We conclude that freezing can induce structural changes of HA, depending on the
type of buffer and freezing rate. The structural integrity of HA during freeze-thawing is
best maintained when HA is dissolved in HBS and when the solution is frozen rapidly.
In most cases, freeze-drying induced more pronounced changes in the structure of HA
than freezing alone, indicating that besides the freezing stresses also the drying stresses
can deteriorate the structure of HA. During drying in PBS, the secondary and tertiary
structure of HA changed to a further extent resulting in increased susceptibility for tryp-
sin cleavage. However freeze-drying of HA in HBS instead of PBS resulted in a less pro-
nounced altered conformation of HA. The tertiary structure of HA in HBS changed to a
further extent during drying, while the secondary structure changed only after slow
freezing and subsequent drying. In conclusion, deterioration of HA during freeze-drying
also depends on the composition of the buffer and the freezing rate.
In order to further protect HA from deterioration during freeze-drying different
carbohydrates were investigated. Differential scanning colorimetry revealed that after
freeze-drying HA was incorporated in a carbohydrate matrix in the amorphous glassy
state (data not shown). First we investigated the influence of carbohydrates on the free-
zing and drying induced damage of HA processed in PBS. After freeze-drying in the pre-
sence of carbohydrates using PBS as buffer no changes in HA structure were found. This
indicates that the carbohydrates prevented the conformational changes of HA induced
by a decrease in pH and lyophilization stress. The carbohydrates also protected HA
during freeze-drying in HBS since no changes in HA structure were found. So, the car-
bohydrates protected the structural integrity of HA from the lyophilization stresses,
irrespective of the type of carbohydrate used. 
Immuno-assays
Besides the maintenance of the structural integrity of the haemagglutinin, it is also
important to investigate whether the antigenic properties of the subunit vaccine are
affected during processing. These properties have been evaluated both in vitro and in
vivo. 
The antigenic properties evaluated in vitro are in line with the results concerning
the structural integrity of HA. HBS was found to be superior to PBS and the carbohydra-
tes used preserved the in vitro antigenic properties of HA upon freeze-drying, indepen-
dently of the type of carbohydrate. 
Furthermore the vaccine powders produced with carbohydrate, except dextran 56
kD, were able to retain their HA potency during storage for at least 26 weeks at
20°C/0%RH. Upon storage at more challenging conditions (45°C/11%RH) the stabilizati-
on of HA was the best for trehalose and the worst for dextran 56 kD. The poor stabiliza-
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tion of HA by dextran might be due to phase separation (during freezing) and/or the bul-
kiness of the dextran molecule (steric hindrance), preventing efficient hydrogen bonding
with the protein [12, 39]. This is in contrast to the small disaccharide trehalose. The less
efficient stabilization of HA at elevated temperatures by the oligosaccharide inulin com-
pared to trehalose might be due to a lower extent and intimacy of hydrogen bond forma-
tion [12]. Overall, the antigen activity of the powders decreased more readily when PBS
was used instead of HBS. Reasons for this could be an improper inclusion in the glass
matrix due to the pH shift during freezing when PBS is used and the capability of HBS
to form an amorphous matrix [40] that acts as a stabilizer during freeze-drying and sto-
rage. 
The immunogenic properties of the subunit vaccine powder were evaluated by
intramuscular immunization of mice. HBS was chosen because HA dissolved in this buf-
fer without carbohydrates displayed the least structural changes after freeze-drying.
Furthermore, despite of the better stabilization capacity of trehalose during storage at
elevated temperatures, inulin 1.8 kD was chosen because of its excellent physicochemi-
cal characteristics such as a high glass transition temperature and high process resistan-
ce which makes it suitable for the development of formulations [13, 14, 41, 42]. The
immunization study revealed that the subunit vaccine in the powder remained immuno-
genic, as determined by IgG-titer and virus-neutralizing capacity of sera. 
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Conclusions
Subunit influenza vaccine can be obtained in the dry state with conservation of the
structural integrity and antigenic properties of HA. When using freeze-drying as drying
method the use of HBS is preferred over PBS. Furthermore preference should be given
to a high freezing rate. Carbohydrates (trehalose, inulin and dextran) appeared to be sui-
table lyoprotectants to retain the antigenic properties of HA after drying. Finally this
research shows that it is possible to produce an influenza subunit vaccine powder as a
stable powder for reconstitution. In addition, the powder may also facilitate the devel-
opment of patient-friendly, non-invasive, dosage forms.
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